Title: Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-
acting antiviral treatment
Version: 1 Date: 31 Jan 2023
Reviewer's report:
Thank you for the provided corrections.
Few minor corrections are required.
-No clear definition or reference was added for classification into younger and older patients
according World Health Organization’s criterion
-Table 1; Why you didn’t add p-value in genotype, although it was mentioned in the text that
genotype 3 was more prevalent in younger patients
-Table 3; Revise heading
-Add references to the new added texts in the discussion.
Title: Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-
acting antiviral treatment
Version: 1 Date: 31 Jan 2023
Reviewer's report:
Thank you for the provided corrections.
Few minor corrections are required.
-No clear definition or reference was added for classification into younger and older patients
according World Health Organization’s criterion
-Table 1; Why you didn’t add p-value in genotype, although it was mentioned in the text that
genotype 3 was more prevalent in younger patients
-Table 3; Revise heading
-Add references to the new added texts in the discussion.
Please review this paper.
user
Title: Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-
acting antiviral treatment
Version: 1 Date: 31 Jan 2023
Reviewer's report:
Thank you for the provided corrections.
Few minor corrections are required.
-No clear definition or reference was added for classification into younger and older patients
according World Health Organization’s criterion
-Table 1; Why you didn’t add p-value in genotype, although it was mentioned in the text that
genotype 3 was more prevalent in younger patients
-Table 3; Revise heading
-Add references to the new added texts in the discussion.
assistant